ReviewDrug delivery2018

Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins.

Xiao-Qin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.